Thomas Ng is a co-founder of GGV Capital and is actively in investing in Asia. He was the founder of Venture TDF in Singapore. Venture TDF pioneered hi-tech venture capital investment in Singapore and China. He advised the Government of Singapore in its development of technopreneurship and served on a number of its Advisory Boards.
Thomas has many years of management and investment experience in the high-technology industry. He has held senior management positions at Solar Energy Research Institute, E.I. DuPont de Nemours & Co. and Genelabs Technologies. He has numerous publications and patents worldwide and currently holds three patents in practice.
Thomas currently serves on the Board of Directors for Sinosun, AAC, Boston-Power and MediaRing. He was a former board member of Oculex (acquired by Allergan).
Thomas earned a B.Sc. in Bacteriology (highest Honor) in 1975, a M.Sc. in Bacteriology in 1977 and a Ph.D. in Bacteriology and Biochemistry in 1981 from the University of Wisconsin at Madison.